Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY 4.0Frontiers in Endocrinology

Gut microbiome alterations and depression in patients with diabetes mellitus: a systematic review and narrative synthesis of the gut-metabolic-brain axis

3 more authors
10 affiliations
  1. 1Department of Family and Community Medicine, College of Medicine, Jazan University
  2. 2Department of Family Medicine, Diabetic Center of King Fahad Central Hospital, Jazan Ministry of Health
  3. 3Department of Obstetrics and Gynecology, College of Medicine, Jazan University
  4. 4Department of Internal Medicine, College of Medicine, Jazan University
  5. 5Department of Basic Medical Sciences (Pathology), College of Medicine, Jazan University
  6. 6Department of Internal Medicine, Rawafed Medical Complex, Ministry of Health
  7. 7Department of Family Medicine, Riyadh First Health Cluster, Ministry of Health
  8. 8Family Medicine Specialist, Primary Healthcare, Ministry of Health
  9. 9Department of Internal Medicine, Jazan General Hospital, Ministry of Health
  10. 10Department of Internal Medicine. Neurology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU)

Abstract

Background: Diabetes mellitus and depression frequently coexist and may share inflammatory, metabolic, neuroendocrine, and behavioral pathways. The intestinal microbiome may represent a biological interface linking metabolic dysfunction with depressive symptoms, but direct human evidence in populations with diabetes remains limited.

Objective: To systematically synthesize direct human evidence on intestinal microbiome alterations associated with depression or depressive symptoms among people with diabetes and interpret the findings within a gut-metabolic-brain axis framework.

Methods: This systematic review followed PRISMA 2020, with search reporting informed by PRISMA-S. Eight databases were searched through August 27, 2026, supplemented by ClinicalTrials.gov, Google Scholar, Research4Life/HINARI, reference lists, and citation tracking. Eligible studies assessed diabetes, depression or depressive symptoms, and intestinal/fecal microbiome data within the same participant sample. Contextual studies not meeting these criteria were considered separately. Owing to substantial clinical and methodological heterogeneity, findings were synthesized qualitatively rather than by meta-analysis.

Results: Database searches identified 1,293 records, with 61 additional unique records from ClinicalTrials.gov. After removing 497 duplicates, 857 records were screened, 94 full-text reports were assessed, and five eligible reports met the eligibility criteria. Three involved type 1 diabetes populations, while two were randomized dietary intervention studies in type 2 diabetes. Across studies, depression or depressive symptoms were associated with differences in intestinal microbial composition and microbiome-related metabolic or neurobiological measures; however, findings varied considerably according to study design, population, depression assessment, and microbiome methodology.

Conclusion: Direct human evidence suggests that depression or depressive symptoms in people with diabetes may be associated with alterations in the intestinal microbiome and related metabolic and neurobiological measures. However, the direct evidence base remains small and heterogeneous, and the available findings are better regarded as hypothesis-generating biological signals than evidence of a consistent microbial signature or causal microbiome-mediated pathway. Larger longitudinal, multi-omics, and intervention studies using standardized microbiome methods, validated depression measures, rigorous confounder adjustment, and mediation analyses are needed.

Related

  1. Depression and Anxiety in Patients with Bullous Pemphigoid: A Systematic Review and Narrative Synthesis.
    Elisabeth Megan Rose Baggus, Arwa Khashkhusha, Salsabeel Khashkhusha +1
    Indian journal of dermatologyPeer-reviewedCC BY-NC-SAFull textGeneral medicineEurope PMCPMC
  2. Can individual gastrointestinal microbiome composition and diversity predict individual clinical response to anti-diabetic medication in human adults? A systematic review and narrative synthesis
    Paul Murray, Fazal Azizuddin, Abdelrahman Hosam Mohammed Attia +2
    Frontiers in EndocrinologyPeer-reviewedCC BY 4.0Endocrinology & metabolismCrossref
  3. Echocardiographic findings in children with malaria: a systematic review and narrative synthesis
    Josephat M. Chinawa, Henrietta U. Okafor
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textEpidemiology & public healthCrossref
  4. Retinal microvascular alterations assessed by OCTA in metabolic liver disease: insights into systemic microvascular dysfunction—a systematic review and semi-quantitative synthesis
    Xu Wang, Zi-qiang Meng
    Frontiers in MedicinePeer-reviewedCC BYFull textGeneral medicineDOAJEurope PMCPMC
  5. Efficacy and Neural Mechanisms of Eye Movement Desensitization and Reprocessing (EMDR) for Depression: A Systematic Review and Qualitative Synthesis
    Ying Li, Jiali Liu, Xintong Wang +1
    Alpha PsychiatryPeer-reviewedCC BY 4.0Full textPsychiatry & mental healthPMC
BibTeX
@article{albasheer2026microbiome,
  title = {{Gut microbiome alterations and depression in patients with diabetes mellitus: a systematic review and narrative synthesis of the gut-metabolic-brain axis}},
  author = {Osama Albasheer and Anas E. Ahmed and Aisha A. Awaf and Areej Hamdi and Abdullah A. Alharbi and Isameldin Medani and Amal H. Mohamed and Fatimah M. Madkhaly and Arafa Omer and Mayada Nogdalla and Wafa Ibrahim and Sameer Alqassimi and Elham Fawzi Shabanh and Amenah Eyas Ali Bajawi and Etedal Ahmed A. Ibrahim},
  journal = {Frontiers in Endocrinology},
  year = {2026},
  month = nov,
  doi = {10.3389/fendo.2026.1982147},
  url = {https://www.frontiersin.org/articles/10.3389/fendo.2026.1982147/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Gut microbiome alterations and depression in patients with diabetes mellitus: a systematic review and narrative synthesis of the gut-metabolic-brain axis
AU  - Osama Albasheer
AU  - Anas E. Ahmed
AU  - Aisha A. Awaf
AU  - Areej Hamdi
AU  - Abdullah A. Alharbi
AU  - Isameldin Medani
AU  - Amal H. Mohamed
AU  - Fatimah M. Madkhaly
AU  - Arafa Omer
AU  - Mayada Nogdalla
AU  - Wafa Ibrahim
AU  - Sameer Alqassimi
AU  - Elham Fawzi Shabanh
AU  - Amenah Eyas Ali Bajawi
AU  - Etedal Ahmed A. Ibrahim
PY  - 2026
DA  - 2026/11/16
JO  - Frontiers in Endocrinology
DO  - 10.3389/fendo.2026.1982147
UR  - https://www.frontiersin.org/articles/10.3389/fendo.2026.1982147/full
AB  - Background: Diabetes mellitus and depression frequently coexist and may share inflammatory, metabolic, neuroendocrine, and behavioral pathways. The intestinal microbiome may represent a biological interface linking metabolic dysfunction with depressive symptoms, but direct human evidence in populations with diabetes remains limited.  Objective: To systematically synthesize direct human evidence on intestinal microbiome alterations associated with depression or depressive symptoms among people with diabetes and interpret the findings within a gut-metabolic-brain axis framework.  Methods: This systematic review followed PRISMA 2020, with search reporting informed by PRISMA-S. Eight databases were searched through August 27, 2026, supplemented by ClinicalTrials.gov, Google Scholar, Research4Life/HINARI, reference lists, and citation tracking. Eligible studies assessed diabetes, depression or depressive symptoms, and intestinal/fecal microbiome data within the same participant sample. Contextual studies not meeting these criteria were considered separately. Owing to substantial clinical and methodological heterogeneity, findings were synthesized qualitatively rather than by meta-analysis.  Results: Database searches identified 1,293 records, with 61 additional unique records from ClinicalTrials.gov. After removing 497 duplicates, 857 records were screened, 94 full-text reports were assessed, and five eligible reports met the eligibility criteria. Three involved type 1 diabetes populations, while two were randomized dietary intervention studies in type 2 diabetes. Across studies, depression or depressive symptoms were associated with differences in intestinal microbial composition and microbiome-related metabolic or neurobiological measures; however, findings varied considerably according to study design, population, depression assessment, and microbiome methodology.  Conclusion: Direct human evidence suggests that depression or depressive symptoms in people with diabetes may be associated with alterations in the intestinal microbiome and related metabolic and neurobiological measures. However, the direct evidence base remains small and heterogeneous, and the available findings are better regarded as hypothesis-generating biological signals than evidence of a consistent microbial signature or causal microbiome-mediated pathway. Larger longitudinal, multi-omics, and intervention studies using standardized microbiome methods, validated depression measures, rigorous confounder adjustment, and mediation analyses are needed.
SN  - 1664-2392
ER  -